ArticleDiabetology & metabolic syndrome2025

Interaction between dipeptidyl-peptidase-4 inhibitors and drugs acting on renin angiotensin aldosterone system for the risk of angioedema: a pharmacovigilance assessment using disproportionality and interaction analyses.

Kannan Sridharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.